Measuring “symptomatic” atrial fibrillation: One view is no view

Atrial fibrillation (AF) has been well documented to contribute to adverse health-related quality of life (HRQoL), an effect measured to be comparable to myocardial infarction.1 Several groups have confirmed these data and demonstrated factors associated with the adverse HRQoL impacts of AF in a variety of different cohorts.2–4 Furthermore, overall improvements in HRQoL have been shown among patients undergoing rhythm control treatment of AF, including catheter ablation.5